type here...

Latest news

Clinical

Pfizer Reports 40% Reduction in Disease Progression Risk With Atirmociclib Combination in Mid-Stage Breast Cancer Study

Pfizer announced that its experimental drug atirmociclib, when used in combination with the hormone therapy fulvestrant, reduced the risk...
Clinical

BioMarin suspends dosing and enrollment in two Voxzogo studies

BioMarin is facing competition from Ascendis Pharma's entry into the achondroplasia field last month and BridgeBio's entry. To make...
Clinical

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

Structure Therapeutics reported results from a mid-stage clinical trial showing that its oral obesity treatment aleniglipron produced significant weight...
Clinical

Eli Lilly Reports Phase 3 Trial Results for Ebglyss in Children With Atopic Dermatitisv

Eli Lilly recorded $408 million in U.S. sales in 2025 for its eczema treatment Ebglyss during the drug’s first...
Commercial

R1 Therapeutics Announces Itself With $77.5M Series A Round to Tackle Kidney Disease

R1 Therapeutics has launched with an oversubscribed $77.5 million...
Clinical

Aspen Reports One-Year Symptom Improvements in Parkinson’s Patients Treated With Sasineprocel

Aspen Neuroscience has reported results from a phase 1/2a...
Regulatory

FDA Approves JenaValve Trilogy System as First Minimally Invasive Implant for Severe Aortic Regurgitation

JenaValve has received approval from the U.S. Food and Drug Administration for its Trilogy transcatheter heart valve system, marking...
Regulatory

FDA Issues Third Rejection for Aldeyra’s Reproxalap in Dry Eye Disease

The U.S. Food and Drug Administration (FDA) has issued a third rejection of Aldeyra Therapeutics’ experimental dry eye disease...
Insights

How Accurate Is AI in Predicting Drug Success?

Drug Success;Artificial intelligence is increasingly used across pharmaceutical research to evaluate whether potential therapies are likely to succeed in...
Insights

FDA Regulatory Challenges for Biotech Companies: What Leaders Need to Know

Executive Summary FDA regulatory challenges for biotech companies in 2026...
Insights

Top 10 Most Credible Pharma and Biotech News Websites in 2026

The pharmaceutical and biotechnology industries depend heavily on reliable...
Insights

Top Pharma and Biotech News Websites to Follow in 2026

The pharmaceutical and biotechnology sectors are among the most dynamic industries in the global economy. Advances in genomics, precision...
Insights

What Will AI Drug Discovery Look Like in 2028?

Executive Summary Artificial intelligence is rapidly transforming pharmaceutical research, and by 2028 AI-driven drug discovery is expected to become a...
Insights

What Is the Competitive Advantage of AI in Pharmaceuticals?

Executive Summary Artificial intelligence is increasingly becoming a source of competitive advantage in pharmaceutical research and development. In 2026, pharmaceutical...
Commercial

R1 Therapeutics Announces Itself With $77.5M Series A Round to Tackle Kidney Disease

R1 Therapeutics has launched with an oversubscribed $77.5 million...
Editorial Team -
Commercial

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C...
Commercial

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

BeOne Medicines is cashing in on its interest in...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Clinical

BioMarin suspends dosing and enrollment in two Voxzogo studies

BioMarin is facing competition from Ascendis Pharma's entry into...
Clinical

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

Structure Therapeutics reported results from a mid-stage clinical trial...
Clinical

Eli Lilly Reports Phase 3 Trial Results for Ebglyss in Children With Atopic Dermatitisv

Eli Lilly recorded $408 million in U.S. sales in...
Insights

What Types of AI Are Used in Drug Discovery?

Executive Summary Artificial intelligence has become a foundational technology in...

Research & Development

Market Access

Manufacturing

Merck expands once more as part of a planned $70 billion US investment

Merck's New Virginia Plant Merck has launched a new $3...
Manufacturing

LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities

German pharmaceutical technology company LTS Lohmann is expanding its...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Manufacturing

Novartis Names Texas as Site For RadioPharma Production Facility

Novartis is moving quickly to outline how radiopharmaceutical manufacturing...
Editorial Team -
Clinical

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

Structure Therapeutics reported results from a mid-stage clinical trial...
Editorial Team -

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice